IDT Price sensitive 20 Aug 2026, 10:35 AM

FY26 Appendix 4E and Annual Report

IDT Australia Ltd

IDT Australia Ltd FY26 Results and Strategic Reset

Key points

  • Revenue from ordinary activities increased by 3.4% to $20,534
  • Loss from ordinary activities decreased by 66.3% to $(2,717)
  • Strategic reset focused on higher-margin services and cost optimization
  • EBITDA improved by over 85% and revenue from core verticals grew by 16.5%
  • Set a three-year aspiration to reach $50 million in annual revenue by FY29

Full summary

IDT Australia Ltd's FY26 results show a 3.4% increase in revenue to $20,534, with a significant 66.3% decrease in loss to $(2,717). The company implemented a strategic reset focusing on higher-margin CDMO services, operating leverage, and financial discipline. This resulted in an 85% improvement in EBITDA and a 16.5% growth in revenue from core verticals. The company also achieved better-than-expected annualised savings of $2.5 million. IDT Australia Ltd aims to reach $50 million in annual revenue by FY29, driven by expanding global client relationships and investing in capabilities to meet unmet demand for advanced therapeutics.

Guidance

EBITDA improved by over 85%, revenue from core verticals grew by 16.5%

Outlook

IDT Australia Ltd aims to reach $50 million in annual revenue by FY29, driven by expanding global client relationships and investing in capabilities to meet unmet demand for advanced therapeutics.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in